Fabrice Egros

Insider Reports History

Location
Waltham, MA
Signature
/s/ Michael A. Metzger, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Fabrice Egros:

Company Role Class Num Shares Value Price $ Report Date Ownership
Syndax Pharmaceuticals Inc Director Common Stock 32,000 $584,483 $18.27 02 Feb 2022 Direct
Syndax Pharmaceuticals Inc Director Stock Options (Right to buy) 0 $19.35 18 Nov 2021 Direct

Insider Reports Filed by Fabrice Egros

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SNDX Syndax Pharmaceuticals Inc 02 Feb 2022 1 $0 4 Director 03 Feb 2022, 16:29
SNDX Syndax Pharmaceuticals Inc 18 Nov 2021 6 -$127,737 4 Director 19 Nov 2021, 15:06
SNDX Syndax Pharmaceuticals Inc 18 Aug 2021 3 -$123,124 4 Director 20 Aug 2021, 16:32
SNDX Syndax Pharmaceuticals Inc 18 May 2021 6 -$154,654 4 Director 20 May 2021, 16:46